Sell 10/23/2024Upgraded
Cannabis Bioscience International Holdings, Inc. (CBIH) was upgraded to D- from E+ on 10/23/2024 due to an increase in the volatility index and solvency index. Debt to equity declined from -0.87 to -0.91.

Sell 10/8/2024Downgrade
Cannabis Bioscience International Holdings, Inc. (CBIH) was downgraded to E+ from D- on 10/8/2024 due to a noticeable decline in the volatility index and total return index.

Sell 6/28/2024Upgraded
Cannabis Bioscience International Holdings, Inc. (CBIH) was upgraded to D- from E+ on 6/28/2024 due to an increase in the volatility index.

Sell 6/13/2024Downgrade
Cannabis Bioscience International Holdings, Inc. (CBIH) was downgraded to E+ from D- on 6/13/2024 due to a noticeable decline in the volatility index, solvency index and efficiency index. Total capital declined 336.17% from -$111.7 to -$487.2, net income declined 68.17% from -$124.4 to -$209.2, and debt to equity increased from -0.83 to -0.48.

Sell 5/5/2023None
Cannabis Bioscience International Holdings, Inc. (CBIH) was downgraded to D- from U on 05/05/2023.